Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. DexCom, Inc.
  6. Calendar
    DXCM   US2521311074

DEXCOM, INC.

(DXCM)
  Report
Delayed Nasdaq  -  04:00 2022-12-08 pm EST
122.67 USD   +4.04%
01:30pDexCom Shares Up 4% After FDA Approval of Continuous Glucose Monitoring System
DJ
11:42aDexCom Secures US FDA Approval for Dexcom G7 Continuous Glucose Monitoring System
MT
08:46aDexcom G7 Receives Fda Clearance : The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart DEXCOM, INC.
Upcoming events on DEXCOM, INC.
02/28/23 FY 2022 Earnings Release (Projected)
05/02/23 Q1 2023 Earnings Release (Projected)
08/01/23 Interim 2023 Earnings Release (Projected)
11/01/23 Q3 2023 Earnings Release (Projected)
Past events on DEXCOM, INC.
11/30/22 | 08:30am Piper Sandler Healthcare Conference
10/27/22 | 04:30pm Q3 2022 Earnings Call
10/27/22 | 04:03pm Q3 2022 Earnings Release
09/14/22 | 08:30am Baird Global Healthcare Conference
09/07/22 | 02:35pm Wells Fargo Healthcare Conference
08/10/22 | 10:30am Canaccord Genuity Growth Conference
07/28/22 | 04:30pm Interim 2022 Earnings Call
07/28/22 | 04:03pm Interim 2022 Earnings Release
06/13/22 SPLIT: 4 of 1
06/08/22 | 05:00pm William Blair Growth Stock Conference
Past dividends on DEXCOM, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
719
714
0,69%
1 032
1 025
0,62%
1 476
1 466
0,72%
1 927
1 915
0,60%
2 449
2 449
-0,03%
 
2 904
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-26,4
-31,1
15%
60,5
22,8
165%
210
176
20%
387
377
2,6%
473
518
-8,8%
 
734
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-42,5
-48,6
12%
31,4
-5,85
637%
161
134
21%
319
314
1,7%
371
389
-4,6%
 
465
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-48,6
-57,2
15%
-127
63,3
-300%
104
73,5
42%
225
264
-15%
174
274
-37%
 
385
 
Net income
M $
Released
Forecast
Spread
-50,2
-43,0
-17%
-127
65,5
-294%
101
64,9
56%
494
236
109%
155
247
-37%
 
362
 
EPS
$
Released
Forecast
Spread
-0,15
-0,12
-22%
-0,36
0,18
-295%
0,28
0,19
48%
1,27
0,56
125%
0,39
0,62
-37%
 
0,90
 
Announcement Date02/27/201802/21/201902/13/202002/11/202102/10/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
650
617
5,4%
698
699
-0,07%
629
624
0,76%
696
698
-0,31%
770
751
2,5%
 
808
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
149
114
31%
131
157
-17%
112
136
-17%
176
176
-0,33%
227
196
16%
 
214
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
124
88,8
39%
99,0
117
-15%
50,3
73,4
-32%
102
103
-0,77%
161
138
16%
 
153
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
90,7
75,3
20%
-14,7
92,8
-116%
36,1
63,0
-43%
75,3
95,9
-21%
146
128
14%
 
149
 
Net income
M $
Released
Forecast
Spread
70,9
61,3
16%
-19,4
76,9
-125%
97,3
50,0
95%
50,9
73,9
-31%
101
96,7
4,7%
 
112
 
EPS
$
Released
Forecast
Spread
0,18
0,16
11%
-0,05
0,20
-125%
0,23
0,12
88%
0,12
0,19
-38%
0,24
0,26
-5,9%
 
0,29
 
Announcement Date10/28/202102/10/202204/28/202207/28/202210/27/2022-
Previous year Next Year
Upcoming sector events for DEXCOM, INC.
More events
Past sector events for DEXCOM, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise